182 related articles for article (PubMed ID: 38334326)
1. Vaginal community state types (CSTs) alter environmental cues and production of the
Maduta CS; McCormick JK; Dufresne K
J Bacteriol; 2024 Mar; 206(3):e0044723. PubMed ID: 38334326
[TBL] [Abstract][Full Text] [Related]
2. Glucose Mediates Niche-Specific Repression of Staphylococcus aureus Toxic Shock Syndrome Toxin-1 through the Activity of CcpA in the Vaginal Environment.
Dufresne K; Podskalniy VA; Herfst CA; Lovell GFM; Lee IS; DeJong EN; McCormick JK; Tuffs SW
J Bacteriol; 2022 Oct; 204(10):e0026922. PubMed ID: 36106854
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Toxic Shock Syndrome-Associated
Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
[TBL] [Abstract][Full Text] [Related]
4. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
Schlievert PM
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) production and Lactobacillus species growth in a defined medium simulating vaginal secretions.
Stingley RL; Liu H; Mullis LB; Elkins CA; Hart ME
J Microbiol Methods; 2014 Nov; 106():57-66. PubMed ID: 25135489
[TBL] [Abstract][Full Text] [Related]
6. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production
Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
Parsonnet J; Hansmann MA; Delaney ML; Modern PA; Dubois AM; Wieland-Alter W; Wissemann KW; Wild JE; Jones MB; Seymour JL; Onderdonk AB
J Clin Microbiol; 2005 Sep; 43(9):4628-34. PubMed ID: 16145118
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
De Boer ML; Kum WW; Chow AW
Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
[TBL] [Abstract][Full Text] [Related]
9. The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.
Pierson JD; Hansmann MA; Davis CC; Forney LJ
Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762733
[TBL] [Abstract][Full Text] [Related]
10. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus producing toxic shock syndrome toxin 1 (TSST-1) in clinical specimens and vaginal swabs in Mannheim, West Germany.
Dickgiesser N; Brombacher A
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):323-9. PubMed ID: 3314262
[TBL] [Abstract][Full Text] [Related]
12. Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus.
MacPhee RA; Miller WL; Gloor GB; McCormick JK; Hammond JA; Burton JP; Reid G
Appl Environ Microbiol; 2013 Mar; 79(6):1835-42. PubMed ID: 23315732
[TBL] [Abstract][Full Text] [Related]
13. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
14. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
15. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
Dickgiesser N; Brombacher A; Wiest W
Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):104-6. PubMed ID: 3569835
[TBL] [Abstract][Full Text] [Related]
16. [Cases of menstrual toxic shock syndrome in the Czech Republic in 1997-2011].
Petrás P; Machová I; Rysková L; Prásil P
Epidemiol Mikrobiol Imunol; 2011 Nov; 60(4):161-6. PubMed ID: 22324245
[TBL] [Abstract][Full Text] [Related]
17. Targeted Proteomics Analysis of Staphylococcal Superantigenic Toxins in Menstrual Fluid from Women with Menstrual Toxic Shock Syndrome (mTSS).
Courçon M; Badiou C; Louwagie M; Etievant S; Jaquinod M; Lina G; Brun V
Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548783
[TBL] [Abstract][Full Text] [Related]
18. Device-Associated Menstrual Toxic Shock Syndrome.
Schlievert PM; Davis CC
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32461307
[TBL] [Abstract][Full Text] [Related]
19. Co-production of staphylococcal enterotoxin A with toxic shock syndrome toxin-1 (TSST-1) enhances TSST-1 mediated mortality in a D-galactosamine sensitized mouse model of lethal shock.
De Boer ML; Kum WW; Pang LT; Chow AW
Microb Pathog; 1999 Aug; 27(2):61-70. PubMed ID: 10458917
[TBL] [Abstract][Full Text] [Related]
20. T-cell response to superantigen restimulation during menstrual toxic shock syndrome.
Rasigade JP; Thomas D; Perpoint T; Peyramond D; Chidiac C; Etienne J; Vandenesch F; Lina G; Ferry T
FEMS Immunol Med Microbiol; 2011 Aug; 62(3):368-71. PubMed ID: 21492259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
